1. Home
  2. INVA

as 07-25-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Founded: 1996 Country:
United States
United States
Employees: N/A City: BURLINGAME
Market Cap: 1.3B IPO Year: 2004
Target Price: $40.33 AVG Volume (30 days): 907.8K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.95 EPS Growth: N/A
52 Week Low/High: $16.67 - $22.00 Next Earning Date: 08-04-2025
Revenue: $369,844,000 Revenue Growth: 18.70%
Revenue Growth (this year): 3.75% Revenue Growth (next year): 12.62%

INVA Daily Stock ML Predictions

Share on Social Networks: